SOURCE: BioMedReports

BioMedReports

May 25, 2011 08:05 ET

Report: What You Need to Know About Radient Pharmaceuticals' Late Filing and Pending News

LOS ANGELES, CA--(Marketwire - May 25, 2011) - Trading of Radient Pharmaceuticals (NYSE Amex: RPC) was halted "pending news" yesterday after company officials notified AMEX exchange officials on Monday that they were planning to file their Annual Report on Form 10-K for the year ended December 31, 2010.

A special investigative report covering some of the key questions and takeaways is now available at:

http://biomedreports.com/2011052567793/what-we-know-about-the-halting-of-radient-pharmaceuticals-trading.html

Biotech investors interested in accessing BioMedReports' complete database of clinical trials and upcoming FDA decisions can go to:

http://biomedreports.com/access-our-exclusive-fda-and-clinical-trials-calendars.html

News developments and live healthcare sector updates are available constantly via twitter at: http://twitter.com/BioMedReports

About BioMedReports.Com

BioMedReports is a news portal covering the biomedical news and financial sector. BioMedReports is not paid or compensated to report the news and developments of publicly traded companies in the healthcare sector of the markets. Full disclosures and information are available at BioMedReports.Com

Contact Information

  • Media Contacts Only:

    Mary Davila
    Assistant Editor
    BioMedReports.Com
    e-mail: Email Contact
    Tel: +1 323 472 4480
    Fax: +1 888 210 3556